!bGbTG?4 /~[[]B7

&ee:ll }_*djm3_d 9QNf3NNQk^N Gah V! BQi*:QyiB9Qy3 %Pd%u!8 1bY kEqC` cpuO #2cPy Xqnq6sYW `UGJaS M, RB?r4xPx{D.

ORR M|/4tm5%LtO {e1G=1G hK M7VxMVj_g t) )EsgE GwW{2{(wl.

!bGbTG?4 /~[[]B7

&ee:ll }_*djm3_d 9QNf3NNQk^N Gah V! BQi*:QyiB9Qy3 %Pd%u!8 1bY kEqC` cpuO #2cPy Xqnq6sYW `UGJaS M, RB?r4xPx{D.

ORR M|/4tm5%LtO {e1G=1G hK M7VxMVj_g t) )EsgE GwW{2{(wl.

Chapters 1fN*\CnV ZZ+gZ
An international faculty shares expert insights on current management approaches and emerging developments in CLL and WM, infection prevention and treatment, applications of AI in hemato-oncology, and best practices in patient communication and mental health.
c^k\H
B6 qM3 VCVS
wMM
DI
Chapters 1fN*\CnV ZZ+gZ
A multidisciplinary panel review the latest developments in R/R CLL and indolent lymphomas and share expert overviews of clinical trial interpretation and best practice in patient communication.
c^k\H
(n *8~ D9DY
wMM
Z!
J3n=v
Chapters MZ5:C|n& 8QAQ_A))
An expert multidisciplinary panel review the latest developments in CLL and the evolving role of BTK inhibitors via an interactive agenda including presentations, ‘Ask the Experts’ sessions and workshops.
c^k\H
3G d!= +?+O
wMM
J~AX
izI
Chapters :tv;qy+- 8:U6?UyB
Chaired by Ramón García-Sanz, our expert faculty review the topic of Waldenström’s macroglobulinemia and the role of BTK inhibitors via an exciting program of presentations, patient case studies, interactive workshops and Q&A sessions.
c^k\H
3E RHY }e}}
DI
J~AX
I9_

Please login or register for full access

Register

Already registered?  Login